Jack Garland

Jack Garland

Auto-generated profile, based on publicly available information

Jack Garland

Forensic and Analytical Science Service, NSW Health Pathology, Sydney, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Forensic Science International
Verified
Journal Article
Closed access
JGJack Garland
Jack Garland
BOBenjamin Ondruschka
Benjamin Ondruschka
UBUgo Da Broi
Ugo Da Broi
CPCristian Palmiere
Cristian Palmiere
RTRexson Tse
Rexson Tse

25 October 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
JZJohann Zwirner
Johann Zwirner
SBSimone Bohnert
Simone Bohnert
HFHeike Franke
Heike Franke
JGJack Garland
Jack Garland
NHNiels Hammer
Niels Hammer
BOBenjamin Ondruschka
Benjamin Ondruschka
Diagnosing traumatic brain injury (TBI) from body fluids in cases where there are no obvious external signs of impact would be useful for emergency physicians and forensic pathologists alike. None of the previous attempts has so far succeeded in establishing a single biomarker to reliably detect TBI with regards to the sensitivity: specificity ratio in a post mortem setting. This study investigated a combination of body fluid biomarkers (obtained post mortem), which may be a step towards increasing the accuracy of biochemical TBI detection. In this study, serum and cerebrospinal fluid (CSF) samples from 30 acute lethal TBI cases and 70 controls without a TBI-related cause of death were evaluated for the following eight TBI-related biomarkers: brain-derived neurotrophic factor (BDNF), ferritin, glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6), lactate dehydrogenase, neutrophil gelatinase-associated lipocalin (NGAL), neuron-specific enolase and S100 calcium-binding protein B. Correlations among the individual TBI biomarkers were assessed, and a specificity-accentuated threshold value analysis was conducted for all biomarkers. Based on these values, a decision tree modelling approach was performed to assess the most accurate biomarker combination to detect acute lethal TBIs. The results showed that 92.45% of acute lethal TBIs were able to be diagnosed using a combination of IL-6 and GFAP in CSF. The probability of detecting an acute lethal TBI was moderately increased by GFAP alone and considerably increased by the remaining biomarkers. BDNF and NGAL were almost perfectly correlated (p = 0.002; R2 = 0.944). This study provides evidence that acute lethal TBIs can be detected to a high degree of statistical accuracy using forensic biochemistry. The high inter-individual correlations of biomarkers may help to estimate the CSF concentration of an unknown biomarker, using extrapolation techniques.

26 October 2020 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
JGJack Garland
Jack Garland
MHMindy Hu
Mindy Hu
KKKilak Kesha
Kilak Kesha
CGCharley Glenn
Charley Glenn
PMPaul Morrow
Paul Morrow
RTRexson Tse
Rexson Tse


29 March 2022 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
RTRexson Tse
Rexson Tse
JGJack Garland
Jack Garland
SMSinead McCarthy
Sinead McCarthy
BOBenjamin Ondruschka
Benjamin Ondruschka
EBEmma N. Bardsley
Emma N. Bardsley
JPJulian F. R. Paton
Julian F. R. Paton

31 December 2019 in American Journal of Forensic Medicine & Pathology
Verified
Journal Article
Closed access
JGJack Garland
Jack Garland
NLNicole Loper
Nicole Loper
WPWinston Philcox
Winston Philcox
BOBenjamin Ondruschka
Benjamin Ondruschka
KKKilak Kesha
Kilak Kesha
RTRexson Tse
Rexson Tse